Jenna L. Koliani‐Pace

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index907citations42works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(31), Microscopic Colitis(26), Eosinophilic Esophagitis(9), Liver Diseases and Immunity(4), Pregnancy and Medication Impact(4)

Publications42 total

S2948 A Unique Case of Pheochromocytoma-Induced Stress Cardiomyopathy Diagnosed After a Screening Colonoscopy
The American Journal of Gastroenterology·2023
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Clinical Gastroenterology and Hepatology·2020· 58 citedOpen Access
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis
Clinical Gastroenterology and Hepatology·2020· 76 citedOpen Access
Systematic review: hepatosplenic T‐cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System
Alimentary Pharmacology & Therapeutics·2020· 47 citedOpen Access
Patients’ Perceive Biologics to Be Riskier and More Dreadful Than Other IBD Medications
Inflammatory Bowel Diseases·2019· 16 cited
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes
Inflammatory Bowel Diseases·2019· 15 citedOpen Access
334 – Development and Validation of a Clinical Scoring Tool for Predicting Treatment Outcomes with Vedolizumab in Patients with Ulcerative Colitis
Gastroenterology·2019· 1 cited
Prognosticating the Course of Inflammatory Bowel Disease
Gastrointestinal Endoscopy Clinics of North America·2019· 24 cited
P631 Development and validation of a clinical scoring tool for predicting treatment outcomes with vedolizumab in patients with ulcerative colitis
Journal of Crohn s and Colitis·2019
Effects of Medical Cannabis on Use of Opioids and Hospital Visits by Patients With Painful Chronic Pancreatitis
Clinical Gastroenterology and Hepatology·2019· 30 cited
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis
Clinical Gastroenterology and Hepatology·2019· 67 citedOpen Access
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
The American Journal of Gastroenterology·2018· 4 cited
Shifts in Vedolizumab Utilization Across the United States Are Associated With Improved Outcomes
The American Journal of Gastroenterology·2018
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
Clinical Gastroenterology and Hepatology·2018· 81 citedOpen Access
Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
The American Journal of Gastroenterology·2018· 172 cited
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease
Gastroenterology·2018· 140 citedOpen Access
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
Inflammatory Bowel Diseases·2018· 74 citedOpen Access
Mo1867 - Shorter Disease Duration is Associated with Higher Response Rates to Vedolizumab in Crohn's Disease but not Ulcerative Colitis: A Multi-Center Consortium Analysis
Gastroenterology·2018· 2 cited
328 - Comparative Effectiveness of Vedolizumab and Tumor Necrosis Factor-Antagonist Therapy in Ulcerative Colitis: A Multicenter Consortium Propensity Score-Matched Analysis
Gastroenterology·2018· 4 cited
Sa1701 - A Multicenter Cohort Study to Assess the Safety of Vedolizumab for Inflammatory Bowel Disease
Gastroenterology·2018
page 1 of 3Next →

Frequent Co-authors

Corey A. Siegel(34), Gursimran Kochhar(28), Eugenia Shmidt(28), Robert Hirten(28), Brigid S. Boland(28), Matthew Bohm(28), Dana J. Lukin(28), Arun Swaminath(28), David Hudesman(28), Sunanda V. Kane(28), Edward V. Loftus(28), Parambir S. Dulai(28), Joseph Meserve(27), William J. Sandborn(27), Siddharth Singh(25), Bo Shen(24), Adam C. Winters(23), David M. Faleck(23), Monika Fischer(23), Karen Lasch(23)